Skip to main content

Table 1 Participants’ demographics and baseline evaluations

From: Comparison between the effects of ultrasound guided intra-articular injections of platelet-rich plasma (PRP), high molecular weight hyaluronic acid, and their combination in hip osteoarthritis: a randomized clinical trial

Characteristic

HA

PRP

PRP + HA

Number

29

32

31

Baseline Characteristics

 Age (y), Mean ± SD

60.93 ± 4.54

58.22 ± 5.10

60.29 ± 4.83

 Sex (male/female), #

7/22

10/22

8/23

 Hip OA grade (2/3), #

16/13

16/16

17/14

 Involved hip (right/left), #

12/17

20/12

17/14

 Pain duration (month), Mean ± SD

3.43 ± 1.53

4.63 ± 2.50

4.26 ± 2.03

 Height (m), Mean ± SD

1.65 ± 0.08

1.67 ± 0.10

1.65 ± 0.09

 Weight (kg), Mean ± SD

74.93 ± 6.30

77.63 ± 10.05

76.03 ± 8.36

 BMI (kg/m2), Mean ± SD

27.62 ± 2.25

27.72 ± 2.11

27.94 ± 2.80

 CBC

Hb (g/dL), Mean ± SD

14.3 ± 1.52

13.59 ± 1.78

13.54 ± 1.70

WBC, (× 103/μL), Mean ± SD

6.34 ± 1.40

6.45 ± 1.12

6.23 ± 1.07

PLT, (× 103/μL), Mean ± SD

269.51 ± 61.07

246.90 ± 9.25

235.83 ± 47.93

 History of physiotherapy (> 1 month) (yes/no), #

13/16

23/9

18/3

 History of previous injection (> 6 months) (No/PRP/HA/CS), #

21/2/5/1

16/7/6/3

18/6/5/2

Outcome Measures,Mean ± SD

 WOMAC

Pain

9.28 ± 1.41

9.53 ± 1.72

9.68 ± 1.49

Stiffness

2.38 ± 1.21

2.75 ± 1.83

2.71 ± 1.01

Function

30.41 ± 8.72

29.09 ± 7.09

28.77 ± 6.84

Total

41.41 ± 11.52

41.38 ± 9.36

41.16 ± 8.13

 VAS

8.10 ± 1.18

7.63 ± 1.31

8.00 ± 1.18

  Lequesne

Pain

5.45 ± 1.02

4.91 ± 1.25

5.16 ± 1.10

MDW

1.79 ± 1.05

1.56 ± 0.67

1.55 ± 0.57

ADL

5.59 ± 0.71

5.63 ± 0.76

5.74 ± 0.67

Total

12.52 ± 2.34

12.20 ± 2.18

12.45 ± 1.66